SE7609979L - Forfaringssett for framstellning av tverbunden orgotein - Google Patents

Forfaringssett for framstellning av tverbunden orgotein

Info

Publication number
SE7609979L
SE7609979L SE7609979A SE7609979A SE7609979L SE 7609979 L SE7609979 L SE 7609979L SE 7609979 A SE7609979 A SE 7609979A SE 7609979 A SE7609979 A SE 7609979A SE 7609979 L SE7609979 L SE 7609979L
Authority
SE
Sweden
Prior art keywords
orgotein
cross
linked
serum albumin
glutaraldehyde
Prior art date
Application number
SE7609979A
Other languages
English (en)
Inventor
W Huber
M G Saifer
L D Williams
Original Assignee
Diagnostic Data Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic Data Inc filed Critical Diagnostic Data Inc
Publication of SE7609979L publication Critical patent/SE7609979L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE7609979A 1975-09-09 1976-09-09 Forfaringssett for framstellning av tverbunden orgotein SE7609979L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/611,658 US4009267A (en) 1975-09-09 1975-09-09 Cross-linked orgotein

Publications (1)

Publication Number Publication Date
SE7609979L true SE7609979L (sv) 1977-03-10

Family

ID=24449918

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7609979A SE7609979L (sv) 1975-09-09 1976-09-09 Forfaringssett for framstellning av tverbunden orgotein

Country Status (18)

Country Link
US (1) US4009267A (sv)
JP (1) JPS5233980A (sv)
AT (1) AT349034B (sv)
BE (1) BE845542A (sv)
CA (1) CA1059911A (sv)
CS (1) CS205040B2 (sv)
DD (1) DD128696A5 (sv)
DE (1) DE2637779A1 (sv)
DK (1) DK396476A (sv)
FI (1) FI57761C (sv)
FR (1) FR2323396A1 (sv)
GB (1) GB1514049A (sv)
IE (1) IE43719B1 (sv)
IL (1) IL50288A (sv)
NL (1) NL7609878A (sv)
NO (1) NO763076L (sv)
SE (1) SE7609979L (sv)
ZA (1) ZA765348B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
IL47468A (en) * 1975-06-12 1979-05-31 Rehovot Res Prod Process for the cross-linking of proteins using water soluble cross-linking agents
CA1146581A (en) * 1977-12-16 1983-05-17 Pieter A. Verbrugge Intermediates in the preparation of cyclopropylcarboxylate esters and process for their manufacture
US4199502A (en) * 1978-08-04 1980-04-22 Warner-Lambert Company Removal of heparin from blood plasma samples using an insoluble protamine reaction product
US4473495A (en) * 1983-07-28 1984-09-25 Northwestern University Albumin-solubilized hymenoptera venoms for vaccine use
US20030069174A1 (en) * 1997-03-10 2003-04-10 Ludwig Pichler Use of human alpha1-acid glycoprotein for producing a pharmaceutical preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687927A (en) * 1971-06-07 1972-08-29 Diagnostic Data Inc Orgotein isolation process employing single ion exchange resin having both acidic and basic groups
US3758682A (en) * 1972-03-23 1973-09-11 Diagnostics Data Inc Pharmaceutical compositions comprising orgotein and their use
US3813289A (en) * 1972-07-19 1974-05-28 Diagnostic Data Inc Orgotein from red blood cells
US3925344A (en) * 1973-04-11 1975-12-09 Community Blood Council Plasma protein substitute

Also Published As

Publication number Publication date
JPS5233980A (en) 1977-03-15
GB1514049A (en) 1978-06-14
CS205040B2 (en) 1981-04-30
CA1059911A (en) 1979-08-07
IE43719B1 (en) 1981-05-06
ATA635976A (de) 1978-08-15
AT349034B (de) 1979-03-12
NL7609878A (nl) 1977-03-11
FI57761C (fi) 1980-10-10
IL50288A (en) 1979-09-30
ZA765348B (en) 1977-09-28
DD128696A5 (de) 1977-12-07
DK396476A (da) 1977-03-10
FR2323396B1 (sv) 1979-09-28
US4009267A (en) 1977-02-22
IL50288A0 (en) 1976-10-31
BE845542A (fr) 1977-02-28
IE43719L (en) 1977-03-09
DE2637779A1 (de) 1977-03-17
FR2323396A1 (fr) 1977-04-08
NO763076L (sv) 1977-03-10
FI57761B (fi) 1980-06-30
FI762567A (sv) 1977-03-10

Similar Documents

Publication Publication Date Title
Swann et al. The isolation and partial characterization of the major glycoprotein (LGP-I) from the articular lubricating fraction from bovine synovial fluid
Maeda et al. Tailor-making of protein drugs by polymer conjugation for tumor targeting: a brief review on smancs
EP0091258B2 (en) Method for stabilizing tumor necrosis factor and a stable aqueous solution or powder containing said factor
Bokisch et al. Third component of complement (C3): structural properties in relation to functions.
Berry et al. Bacterial toxins
Laskov et al. Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells: I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits
Lewis et al. Immunological studies in nephrotic syndrome associated with extrarenal malignant disease
US4022888A (en) Esterified orgotein
EP0090892B1 (en) Process for the purification of physiologically active substance having antitumour activity
US3928580A (en) Injectable glycoproteins containing terminal {37 C{38 {0 ends of human immunoglobulins
GB2056276A (en) Formulation of rifamycin sv and salts derived therefrom for treating rheumatoid arthritis
SE7609979L (sv) Forfaringssett for framstellning av tverbunden orgotein
GB1420411A (en) Pyridine compounds and process for their manufacture
Dixit et al. Studies on rats with islet beta cell tumors induced by nicotinamide and streptozotocin
McDaniel et al. Association of macrophage-activation factor from a human cultured lymphoid cell line with albumin and α2-macroglobulin
Ternell et al. Plasma protein synthesis in experimental cancer compared to paraneoplastic conditions, including monokine administration
ES420846A1 (es) Metodo de preparacion de un concentrado de globulina gamma altamente soluble.
US4968495A (en) Chemically modified bilirubin oxidase
ES427385A1 (es) Procedimiento para la preparacion de una fraccion de sangreque contenga una elevada concentracion de albumina y globu- linas alfa y beta.
EP0002452B1 (en) Glycoprotein isolated from aloe
Boissevain Growth promotion of the tubercle bacillus by serum albumen
Polak et al. In vitro sensitisation to dinitrochlorobenzene in guinea pigs
Green et al. The effect of N-bromosuccinimide on the sub-unit structure of avidin and its complexes with biotin
US4062949A (en) Abrin composition of reduced toxicity
US3130189A (en) Hydroxocobalamin-glutathione

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7609979-5

Format of ref document f/p: F